Post-transplant renal anemia: a call to action from a national study in routine clinical practice
We found that hemoglobin targets are individualized upwards in post-transplant anemia. In this setting, iron therapy continues to be underutilized, especially intravenous, and iron deficiency and prior events (blood transfusion or hospital admission) explain most of the hyporesponsiveness to ESA. This highlights missed opportunities for precise prescription targeting and adherence to established guidelines, suggesting a need for improved management strategies in post-transplant anemia patients.
Authors
- Marta Crespo (ORCID: https://orcid.org/0000-0002-1852-2259)
- Álex Gutiérrez-Dalmau (ORCID: https://orcid.org/0000-0002-2253-7779)
- Laia Oliveras (ORCID: https://orcid.org/0009-0002-5317-7304)
- Núria Montero (ORCID: https://orcid.org/0000-0002-5123-4603)
- José María Portolés (ORCID: https://orcid.org/0000-0002-2114-1385)
- Auxiliadora Mazuecos (ORCID: https://orcid.org/0000-0002-5860-2309)
- Paula López–Sánchez (ORCID: https://orcid.org/0000-0002-4332-5759)
- Asunción Sancho (ORCID: https://orcid.org/0000-0002-4170-9003)
- Emma Calatayud Aristoy
- Julio Pascual (ORCID: https://orcid.org/0000-0002-4735-7838)
- Eduardo Martínez Morales
- Miguel Martínez Belotto
- Arhsdeep Singh
- Sthefanny Carolina González Garcia
- Julio Colina
- Emilio Rodrigo Calabia
Institutions
- Bellvitge University Hospital (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Hospital Universitario Doctor Peset (ES)
- Hospital Del Mar (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Spanish Society of Hematology and Hemotherapy (ES)
- Hospital Universitario Puerta del Mar (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/ckj/sfae269
- Citations
- 4
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- GlaxoSmithKline
- Sociedad Española de Nefrología